patients undergoing hepatectomy by continuous dosing rocuronium
Conditions
Interventions
continuous dose of rocuronium while occlusion of liver blood flow
Sponsors
Nihon university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients undergo hepatectomy
Exclusion criteria
Exclusion criteria: patients with PS higher than 3 in ASA classification
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate duration time of continuous dosing rocuronium in pre and post occlusion of liver blood flow during hepatectomy | — |
Countries
Japan
Contacts
Public Contactmai yamamoto
Nihon university school of medicine Department of anesthesiology
Outcome results
None listed